Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Exp Cell Res ; 317(10): 1465-75, 2011 Jun 10.
Artigo em Inglês | MEDLINE | ID: mdl-21514295

RESUMO

Translocation to cellular membranes is one of the hallmarks of PKC activation, occurring as a result of the generation of lipid secondary messengers in target membrane compartments. The activation-induced translocation of PKCs and binding to membranes is largely directed by their regulatory domains. We have previously reported that PKCη, a member of the novel subfamily and an epithelial specific isoform, is localized at the cytoplasm and ER/Golgi and is translocated to the plasma membrane and the nuclear envelope upon short-term activation by PMA. Here we show that PKCη is shuttling between the cytoplasm and the nucleus and that upon etoposide induced DNA damage is tethered at the nuclear envelope. Although PKCη expression and its phosphorylation on the hydrophobic motif (Ser675) are increased by etoposide, this phosphorylation is not required for its accumulation at the nuclear envelope. Moreover, we demonstrate that the C1b domain is sufficient for translocation to the nuclear envelope. We further show that, similar to full-length PKCη, the C1b domain could also confer protection against etoposide-induced cell death. Our studies demonstrate translocation of PKCη to the nuclear envelope, and suggest that its spatial regulation could be important for its cellular functions including effects on cell death.


Assuntos
Neoplasias da Mama/metabolismo , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Dano ao DNA , Membrana Nuclear/metabolismo , Proteína Quinase C-delta/genética , Proteína Quinase C-delta/metabolismo , Animais , Antineoplásicos Fitogênicos/farmacologia , Células COS , Núcleo Celular/efeitos dos fármacos , Células Cultivadas , Chlorocebus aethiops , Citoplasma/efeitos dos fármacos , Etoposídeo/farmacologia , Citometria de Fluxo , Imunofluorescência , Humanos , Estrutura Terciária de Proteína , Transporte Proteico/efeitos dos fármacos , Frações Subcelulares
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...